Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
One-Off GT3-Powered Porsche 996 Classic Club Coupe Sells for $1.2 Million at Auction
The Porsche 911 Classic Club Coupe is arguably the coolest 996 in existence. It’s a one-off creation built in a collaboration between Porsche Classic and the Porsche Club of America, with
